Skip To Content
JEWISH. INDEPENDENT. NONPROFIT.
Breaking News

Ryan Braun, the Hebrew Hammer, May Receive Record Suspension for Drugs

Milwaukee Brewers slugger Ryan Braun, nicknamed “The Hebrew Hammer,” could be subject to the longest suspension ever by Major League Baseball for using performance enhancing drugs, according to reports by ESPN.

Braun, was the National League MVP in 2011 and is a five-time All-Star. However, for two years now he has been suspected of purchasing performance enhancing drugs (known as PEDs) from the lab Biogenesis of America and could receive a 100-game suspension from the league.

Tom Bosch, founder of Biogenesis of America, a lab that reportedly provided performance enhancing drugs to numerous baseball players, has been cooperating with Major League Baseball to provide information on his client list.

After the news surfaced of the possibility of a new ban, Braun told reporters, “I addressed it in spring training. The truth has not changed. I don’t know the specifics of the story that came out today, but I’ve already addressed it. I’ve commented on it. I’ll say nothing further about it.”

In October 2011, Braun tested positive for elevated testosterone and was handed a 50-game suspension. However, he denied any drug use and successfully appealed the ruling.

If suspended this season, he will be the highest profile player to receive such a penalty during the height of his career. Braun, 29, is coming off a season where he hit a career-high 41 home runs, but only has nine through 53 games in 2013 so far.

Other notable players MLB is targeting include Yankees slugger Alex Rodriguez, Blue Jays outfielder Melky Cabrera and Rangers outfielder Nelson Cruz.

Officials from Major League Baseball will meet with Bosch on Friday and then decide on whether or not to proceed with the suspensions.

A message from our CEO & publisher Rachel Fishman Feddersen

I hope you appreciated this article. Before you go, I’d like to ask you to please support the Forward’s award-winning, nonprofit journalism during this critical time.

We’ve set a goal to raise $260,000 by December 31. That’s an ambitious goal, but one that will give us the resources we need to invest in the high quality news, opinion, analysis and cultural coverage that isn’t available anywhere else.

If you feel inspired to make an impact, now is the time to give something back. Join us as a member at your most generous level.

—  Rachel Fishman Feddersen, Publisher and CEO

With your support, we’ll be ready for whatever 2025 brings.

Republish This Story

Please read before republishing

We’re happy to make this story available to republish for free, unless it originated with JTA, Haaretz or another publication (as indicated on the article) and as long as you follow our guidelines. You must credit the Forward, retain our pixel and preserve our canonical link in Google search.  See our full guidelines for more information, and this guide for detail about canonical URLs.

To republish, copy the HTML by clicking on the yellow button to the right; it includes our tracking pixel, all paragraph styles and hyperlinks, the author byline and credit to the Forward. It does not include images; to avoid copyright violations, you must add them manually, following our guidelines. Please email us at editorial@forward.com, subject line “republish,” with any questions or to let us know what stories you’re picking up.

We don't support Internet Explorer

Please use Chrome, Safari, Firefox, or Edge to view this site.

Exit mobile version